April A Rose

April A N Rose

UNVERIFIED PROFILE

Are you April A N Rose?   Register this Author

Register author
April A Rose

April A N Rose

Publications by authors named "April A N Rose"

17Publications

322Reads

46Profile Views

1PubMed Central Citations

BRAF Mutation Class and Clinical Outcomes-Letter.

Clin Cancer Res 2019 May;25(10):3188

Faculty of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0080DOI Listing
May 2019

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

Oncogene 2018 06 15;37(24):3183-3199. Epub 2018 Mar 15.

Goodman Cancer Research Centre, McGill University, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0171-xDOI Listing
June 2018

Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer.

Pharmacol Ther 2017 Nov 22;179:127-141. Epub 2017 May 22.

Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada; Department of Medicine, McGill University, Montréal, Québec, Canada; Department of Biochemistry, McGill University, Montréal, Québec, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, Québec, Canada; Department of Oncology, McGill University, Montréal, Québec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2017.05.010DOI Listing
November 2017

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer.

J Clin Oncol 2014 Nov 29;32(32):3619-25. Epub 2014 Sep 29.

Johanna Bendell and Suzanne Jones, Sarah Cannon Research Institute, Nashville, TN; Mansoor Saleh, Georgia Cancer Specialists, Atlanta, GA; April A.N. Rose and Peter M. Siegel, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada; Lowell Hart, Florida Cancer Specialists, Fort Myers; Surendra Sirpal, Hematology Oncology Associates, Lake Worth, FL; Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, and Thomas Davis, Celldex Therapeutics; and Linda Vahdat, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.5683DOI Listing
November 2014

Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis.

Breast Cancer Res Treat 2013 Oct 9;141(3):331-9. Epub 2013 Oct 9.

Faculty of Medicine, McGill University, McIntyre Medical Building, 3655 Sir William Osler, Montreal, QC, H3G 1Y6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2713-9DOI Listing
October 2013

Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells.

Am J Pathol 2010 Jun 9;176(6):3023-31. Epub 2010 Apr 9.

Institut national de la recherche scientifique-Institut Armand-Frappier, Laval, Québec, Canada, H7V 1B7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2010.090876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877862PMC
June 2010

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.

Clin Cancer Res 2010 Apr 9;16(7):2147-56. Epub 2010 Mar 9.

Department of Medicine, Goodman Cancer Research Centre, McGill University, 1160 Pine Avenue West Montréal, Québec, Canada, H3A 1A3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1611DOI Listing
April 2010

Emerging therapeutic targets in breast cancer bone metastasis.

Future Oncol 2010 Jan;6(1):55-74

Department of Medicine, Goodman Cancer Centre, McGill University, QC H3A 1A3, Canada.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon.09.138
Publisher Site
http://dx.doi.org/10.2217/fon.09.138DOI Listing
January 2010

Osteoactivin promotes breast cancer metastasis to bone.

Mol Cancer Res 2007 Oct;5(10):1001-14

Department of Medicine, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://mcr.aacrjournals.org/cgi/doi/10.1158/1541-7786.MCR-07
Publisher Site
http://dx.doi.org/10.1158/1541-7786.MCR-07-0119DOI Listing
October 2007

Breast cancer-derived factors facilitate osteolytic bone metastasis.

Bull Cancer 2006 Sep;93(9):931-43

Department of Medicine, McGill University, 740 Dr. Penfield Avenue, Room 2201, Montreal, Quebec, Canada, H3A 1A4.

View Article

Download full-text PDF

Source
September 2006